About VIB (111)
Bio imaging core (1)
Business opportunities (16)
Cardiovascular medicine (25)
Cell biology (13)
Developmental biology (6)
Inflammation and immunity (49)
International PhD Program (1)
Model Organisms (2)
Plant biology (89)
Research Areas (5)
Science ethics (2)
Structural biology (22)
Systems biology (7)
BioInformatics Training and Service facility (1)
Research services (5)
Page Content Zone 1
Anxiety increases the risk of gastrointestinal infection and long-term complications
2 July 2015
A team comprised of scientists at VIB, KU Leuven and UZ Leuven has made significant progress in uncovering the connection between psychological factors and the immune system.
How to kill a spill
1 July 2015
Tips and tricks on how can clean spills in teh lab safely.
Peter Vandenabeele (VIB-UGent) receives FWO excellence prize
1 July 2015
Every five years, FWO Flanders selects five exceptional scientists in Flanders who play an international leading role in their field and have pushed the boundaries of their field.
Immunovaccine Initiates Clinical Trial with DPX-RSV Vaccine
30 June 2015
Immunovaccine Inc. announced that it has enrolled the first healthy adult volunteer in a Phase 1 clinical study of its respiratory syncytial virus (RSV) vaccine.
Oncurious NV Appoints Prof Dr Peter Carmeliet as its Chief Scientific Strategy Advisor
26 June 2015
Oncurious NV, an oncology company focused on the development of innovative medicines for the treatment of pediatric tumors, today announces the appointment of Prof. Dr Peter Carmeliet as its Chief Scientific Strategy Advisor.
New biotech company Confo Therapeutics launched by VIB and Vrije Universiteit Brussel: Capricorn Venture Partners leads 1st financing round of € 3 million
24 June 2015
The establishment of Confo Therapeutics, a spin-off of VIB and Vrije Universiteit Brussel, was announced today. A consortium led by Capricorn Health-Tech Fund with the participation of Qbic and SOFI.
New insights could result in changes to the therapeutic strategy to combat Alzheimer’s
26 May 2015
Scientists at VIB, KU Leuven and Janssen Pharmaceutica have demonstrated that the distribution of aggregates through the brain is facilitated by synaptic connections between brain cells.
VIB and Performa Investimentos establish GlobalYeast to deliver superior industrial yeast strains for the bio based economy
21 May 2015
VIB and Performa Investimentos today announced the establishment of GlobalYeast, a new company that will develop and deliver superior industrial yeast strains for bioethanol and the green chemicals industry.
Tara Oceans expedition sheds light on the world of plankton
21 May 2015
Plankton is our most important source of oxygen.
How risky is working at VIB
18 May 2015
Overview of accidents at VIB.
Novel insights in MET-proto-oncogene might lead to optimizing cancer treatment
18 May 2015
The MET-proto-oncogene is involved in the pathogenesis of several tumors and therefore represents an interesting target for future therapies currently tested in dozens of clinical trials.
A step forward in understanding muscle diseases
4 May 2015
Rouslan Efremov, together with his former colleagues from Max Planck, unraveled the structure and mechanism of the ryanodine receptor.
Quickscan scientific publications 1st quarter 2015
27 April 2015
VIB's scientific publications 1st quarter 2015
The genome sequence of the orchid Phalaenopsis equestris
20 April 2015
The lab of Yves Van de Peer (VIB Department of Plant Systems Biology) can add an extra genome paper to its long list.
Cell sorting at VIB
16 April 2015
Cell sorting technology enables rapid separation of large numbers of specific cell populations with high purity, recovery, and yield, starting from single cell suspensions.
Page Content Zone 2
Page Content Zone 3
Get news updates:
Follow us on Twitter
Like us on Facebook
Inflammation and immunity
Training and facilities
Int. Ph.D. Program